home / stock / nviv / nviv short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 27,444 |
Total Actual Volume | 223,923 |
Short Trends | |
---|---|
Cover Days | 12 |
Short Days | 4 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 1,372 |
Average Short Percentage | 28.13% |
Is there a NVIV Short Squeeze or Breakout about to happen?
See the NVIV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-30 | 4.34 | 4.0501 | 4.46 | 4.05 | 11,960 | 438 | 6.2005 |
2022-06-29 | 4.31 | 4.105 | 4.498 | 4.0564 | 2,173 | 12 | 1.4235 |
2022-06-28 | 4.61 | 4.4492 | 4.8 | 4.2982 | 17,023 | 1,080 | 13.4328 |
2022-06-27 | 4.05 | 4.22 | 4.22 | 4.05 | 1,809 | 168 | 18.8341 |
2022-06-24 | 3.99 | 4.155 | 4.4 | 3.99 | 7,134 | 654 | 20.0368 |
2022-06-23 | 4.25 | 4 | 4.287 | 4 | 3,445 | 321 | 35.9060 |
2022-06-22 | 3.77 | 4.15 | 4.23 | 3.6235 | 13,079 | 3,299 | 58.8057 |
2022-06-21 | 3.74 | 3.94 | 3.95 | 3.62 | 26,034 | 4,016 | 33.5058 |
2022-06-16 | 3.74 | 3.81 | 3.88 | 3.6025 | 10,032 | 928 | 11.8716 |
2022-06-15 | 3.75 | 3.93 | 3.97 | 3.73 | 7,102 | 425 | 17.6202 |
2022-06-14 | 4.05 | 3.86 | 4.05 | 3.76 | 5,455 | 1,213 | 51.0952 |
2022-06-13 | 4.35 | 3.81 | 4.35 | 3.8 | 17,084 | 703 | 7.0767 |
2022-06-09 | 4.75 | 4.7546 | 5 | 4.69 | 4,696 | 478 | 24.0201 |
2022-06-08 | 4.7 | 4.872 | 4.99 | 4.7 | 6,550 | 1,830 | 40.1052 |
2022-06-06 | 5.05 | 4.9 | 5.3877 | 4.8901 | 10,244 | 3,793 | 51.3539 |
2022-06-03 | 4.89 | 4.89 | 5 | 4.88 | 3,970 | 545 | 53.5890 |
2022-06-02 | 5.39 | 5.08 | 5.5 | 5.07 | 9,196 | 526 | 21.2011 |
2022-06-01 | 5.52 | 5.39 | 5.52 | 5.22 | 3,533 | 404 | 18.5662 |
2022-05-31 | 4.94 | 5.32 | 5.52 | 4.94 | 56,601 | 5,768 | 36.9696 |
2022-05-26 | 4.6437 | 4.83 | 4.85 | 4.64 | 6,803 | 843 | 41.0619 |
InVivo Therapeutics Holdings Corp. Company Name:
NVIV Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Manuscript details patient outcomes through 24-month follow up visit InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a peer-reviewed manuscript in Neurosurgery describing the previously disclosed 12- and 24-month data from the Company...
Topline data expected to be reported in Q1 2023 InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that it has completed enrollment in ...
InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcom...